PDL BioPharma (PDLI) Reports Q4 EPS of $0.17, Misses by 2c
Tweet Send to a Friend
In it's Form 10-K, PDL BioPharma, Inc. (Nasdaq ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


